Published in J Enzyme Inhib on January 01, 1993
The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc Natl Acad Sci U S A (2003) 1.62
Prognostic classification of breast ductal carcinoma-in-situ. Lancet (1995) 2.70
Mechanism for transition from initial to stable cell-cell adhesion: kinetic analysis of E-cadherin-mediated adhesion using a quantitative adhesion assay. J Cell Biol (1996) 2.20
Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 1.94
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A (1994) 1.91
Ace/Fgf8 is required for forebrain commissure formation and patterning of the telencephalon. Development (2000) 1.50
Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer (1995) 1.41
[Chronic anemia and abdominal pain as a sequela of lead poisoning]. Dtsch Med Wochenschr (2001) 1.38
Isolated infarcts of the pons. Neurology (1996) 1.25
The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B. Biochem J (1989) 1.25
The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol (1987) 1.24
A clinical physiologic study of hydroxyethyl starch. Surg Gynecol Obstet (1970) 1.22
Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J Neurosci (1995) 1.16
Reaction-induced infrared difference spectroscopy for the study of protein reaction mechanisms. Biochemistry (2001) 1.12
Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes (1998) 1.10
Stress and the menstrual cycle: relevance of cycle quality in the short- and long-term response to a 5-day endotoxin challenge during the follicular phase in the rhesus monkey. J Clin Endocrinol Metab (1998) 1.10
Prolyl tripeptidyl peptidase from Porphyromonas gingivalis. A novel enzyme with possible pathological implications for the development of periodontitis. J Biol Chem (1999) 1.09
[Studies on the purification and characterization of dipeptidyl aminopeptidase IV]. Acta Biol Med Ger (1974) 1.08
Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference. Behav Pharmacol (2002) 1.08
Structure of the complex of proteinase K with a substrate analogue hexapeptide inhibitor at 2.2-A resolution. J Biol Chem (1993) 1.07
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis (2003) 1.06
Effects of cerebral perfusion pressure and increased fraction of inspired oxygen on brain tissue oxygen, lactate and glucose in patients with severe head injury. Acta Neurochir (Wien) (2003) 1.05
Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs. J Biol Chem (2000) 1.01
P(3)-[2-(4-hydroxyphenyl)-2-oxo]ethyl ATP for the rapid activation of the Na(+),K(+)-ATPase. Biophys J (2000) 1.01
Imaging tumors with peptide-based radioligands. Q J Nucl Med (2001) 1.00
Enzyme-substrate interactions in the hydrolysis of peptide substrates by thermitase, subtilisin BPN', and proteinase K. Arch Biochem Biophys (1986) 0.99
Measles outbreak in an asylum-seekers' shelter in Germany: comparison of the implemented with a hypothetical containment strategy. Epidemiol Infect (2011) 0.98
Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol (1993) 0.98
Dipeptidyl peptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand J Immunol (1989) 0.97
Long-term follow-up of an epidemiologically defined cohort of patients with Tourette syndrome. J Child Neurol (2001) 0.97
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide. Metabolism (1999) 0.97
Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Eur J Biochem (1996) 0.95
Structural changes of the sarcoplasmic reticulum Ca(2+)-ATPase upon nucleotide binding studied by fourier transform infrared spectroscopy. Biophys J (2000) 0.94
The influence of chronic stress on multiple opioid peptide systems in the rat: pronounced effects upon dynorphin in spinal cord. Brain Res (1987) 0.94
Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes. Clin Chim Acta (1992) 0.94
Diffusion-weighted MRI for monitoring neurovascular interventions. Neuroradiology (2000) 0.93
Vaccine therapy for malignant melanoma. CA Cancer J Clin (1996) 0.93
Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum. Biochim Biophys Acta (1988) 0.93
Side-chain protonation and mobility in the sarcoplasmic reticulum Ca2+-ATPase: implications for proton countertransport and Ca2+ release. Biophys J (2007) 0.92
Internal artificial vagina (IAV) to assess breeding behavior of young Bos taurus and Bos indicus bulls. Anim Reprod Sci (2011) 0.91
Antibacterial activities of temporin A analogs. FEBS Lett (2000) 0.91
Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med (2000) 0.90
A case of hydrocephalus occlusus presenting as bipolar disorder. Acta Psychiatr Scand (2005) 0.90
Diagnostic management of orthostatic intolerance in the workplace. Int Arch Occup Environ Health (2002) 0.90
Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol Chem Hoppe Seyler (1991) 0.89
Effect of aging and diabetes on the enteroinsular axis. J Gerontol A Biol Sci Med Sci (2001) 0.89
Enzyme-substrate interactions in the hydrolysis of peptides by cathepsins B and H from rat liver. Biochem J (1987) 0.88
Nocturnal positional lumboischialgia: presenting symptom of lumbar spinal tumours. J Neurol (2008) 0.88
Magnetic resonance angiography with ultrashort echo times reduces the artefact of aneurysm clips. Neuroradiology (2002) 0.87
Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol (2007) 0.87
Cases of community-acquired meticillin-resistant Staphylococcus aureus in an asylum seekers centre in Germany, November 2010. Euro Surveill (2011) 0.86
[Synthesis and properties of 1-chloro-3-amino-4-phenyl-butanone-2, an inhibitor of leucine aminopeptidase from bovine eye lenses]. Acta Biol Med Ger (1972) 0.86
The conformation around the peptide bond between the P1- and P2-positions is important for catalytic activity of some proline-specific proteases. Biochim Biophys Acta (1983) 0.85
Digital image analysis of self-similar cell profiles. Int J Biomed Comput (1994) 0.85
Identification of catecholamines in the immune system by electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom (1998) 0.84
Antimicrobial peptides derived from heme-containing proteins: hemocidins. Antonie Van Leeuwenhoek (2000) 0.84
Dipeptidylpeptidase IV--inactivation with N-peptidyl-O-aroyl hydroxylamines. J Enzyme Inhib (1988) 0.84
Substrates containing phosphorylated residues adjacent to proline decrease the cleavage by proline-specific peptidases. Biochim Biophys Acta (1996) 0.84
Role of dipeptidyl peptidase IV in uptake of peptide nitrogen from beta-casomorphin in rabbit renal BBMV. Am J Physiol (1987) 0.84
Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylproline p-nitroanilide in T-lymphocytes. Biochem J (1984) 0.84
Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases. In Vivo (1991) 0.84
N,O-diacyl hydroxamates as selective and irreversible inhibitors of cysteine proteinases. Methods Enzymol (1994) 0.83
Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects. J Med Chem (1994) 0.83
Peptide methyl ketones as reversible inhibitors of cysteine proteinases. J Enzyme Inhib (1989) 0.83
Crystal structure of subtilisin DY, a random mutant of subtilisin Carlsberg. Eur J Biochem (1998) 0.83
N,O-diacylhydroxylamines as enzyme-activated inhibitors for serine proteases. Pharmazie (1983) 0.83
Granuloma formation and occlusion of an unruptured aneurysm after wrapping. Acta Neurochir (Wien) (2007) 0.83
The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth. J Biol Chem (1997) 0.83
Lead exposure levels and duration of exposure absence predict neurobehavioral performance. Int Arch Occup Environ Health (2005) 0.83
[Kinetics of dipeptidyl-peptidase IV]. Acta Biol Med Ger (1978) 0.83
Influence of magnesium on the intestinal absorption of lead. Environ Res (1976) 0.82
Derivatives of beta-casomorphins with high analgesic potency. Peptides (1984) 0.82
Capillary liquid chromatography-fast atom bombardment mass spectrometry using a high-resolving cation exchanger, based on a continuous chromatographic matrix. Application to studies on neuropeptide peptidases. J Chromatogr B Biomed Appl (1995) 0.82
Synthesis of dipeptide 4-nitroanilides containing non-proteinogenic amino acids. Int J Pept Protein Res (1995) 0.82
Analysis of a putative voltage-gated prokaryotic potassium channel. Eur J Biochem (2001) 0.82
Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability. J Nucl Med (1995) 0.82
Structural changes of sarcoplasmic reticulum Ca(2+)-ATPase upon Ca2+ binding studied by simultaneous measurement of infrared absorbance changes and changes of intrinsic protein fluorescence. Biochim Biophys Acta (1994) 0.81
Biotransformation of nociceptin/orphanin FQ by enzyme activity from morphine-naive and morphine-treated cell cultures. Brain Res (1999) 0.81
Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its released fragment. Peptides (1999) 0.81
Peptide diazomethyl ketones are inhibitors of subtilisin-type serine proteases. J Enzyme Inhib (1990) 0.81
Excretion of lithium by kidney, bile and faeces in rats of different ages. Arch Int Pharmacodyn Ther (1982) 0.81
Reactions between dipeptidyl peptidase IV and diacyl hydroxylamines: mechanistic investigations. J Enzyme Inhib (1989) 0.81
Hematological and antifungal properties of temporin A and a cecropin A-temporin A hybrid. Acta Biochim Pol (2001) 0.81
Crystallization and preliminary X-ray analysis of subtilisin DY, a natural mutant of subtilisin Carlsberg. Arch Biochem Biophys (1993) 0.81
Identification of functional domains in Efb, a fibrinogen binding protein of Staphylococcus aureus. Biochem Biophys Res Commun (1998) 0.80
Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance. Int Arch Occup Environ Health (2005) 0.80
Comparison of synthesis and antibacterial activity of temporin A. FEBS Lett (1999) 0.80
[Thermitase--a thermostable serine protease. VI. Kinetic and fluorescence studies on the interaction of the enzymes with dansylated peptide chloromethylketones]. Biomed Biochim Acta (1984) 0.80
A model of the active site of dipeptidyl peptidase IV predicted by comparative molecular field analysis and molecular modelling simulations. Int J Pept Protein Res (1995) 0.80
Start-to-end processing of two-dimensional gel electrophoretic images. J Chromatogr A (2007) 0.80
Orphanin FQ/nociceptin inhibits morphine withdrawal. Life Sci (2000) 0.80
Elastinolytic activity of horse leukocyte proteinases. Comparison with elastases from human leukocytes and porcine pancreas. Folia Histochem Cytobiol (1986) 0.80
Enzymic properties of intestinal aminopeptidase P: a new continuous assay. FEBS Lett (1988) 0.80
Metabolism of beta-endorphin in plasma studied by liquid chromatography-electrospray ionization mass spectrometry. Regul Pept (1998) 0.79
Cerebral revascularization model in a swine. Acta Neurochir Suppl (2005) 0.79